Trial Profile
Comparison of efficacy and renal function of everolimus versus mycophenolate in combination with tacrolimus based immunosuppressive regimens in kidney transplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate (Primary) ; Tacrolimus
- Indications Graft-versus-host disease; Renal transplant rejection
- Focus Therapeutic Use
- 08 Oct 2016 New trial record